General Information of Drug Transporter (DT)
DT ID DTD0452 Transporter Info
Gene Name SLC6A2
Transporter Name Sodium-dependent noradrenaline transporter
Gene ID
6530
UniProt ID
P23975
Epigenetic Regulations of This DT (EGR)

Methylation

  Hepatocellular carcinoma

         29 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

5'UTR (ch.20.983686F)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.27E+00 Statistic Test p-value: 4.41E-12; Z-score: -1.03E+00

Methylation in Case

7.03E-02 (Median) Methylation in Control 8.93E-02 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

TSS1500 (cg24125468)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.47E+00 Statistic Test p-value: 1.03E-15; Z-score: -3.73E+00

Methylation in Case

5.00E-01 (Median) Methylation in Control 7.34E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

TSS1500 (cg07992308)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.35E+00 Statistic Test p-value: 1.36E-14; Z-score: -4.62E+00

Methylation in Case

4.56E-01 (Median) Methylation in Control 6.16E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

TSS1500 (cg02693870)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.49E+00 Statistic Test p-value: 9.89E-08; Z-score: -2.36E+00

Methylation in Case

2.29E-01 (Median) Methylation in Control 3.42E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

TSS1500 (cg01277542)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.15E+00 Statistic Test p-value: 2.09E-03; Z-score: -1.74E-01

Methylation in Case

3.39E-02 (Median) Methylation in Control 3.92E-02 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

TSS1500 (cg27047406)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.09E+00 Statistic Test p-value: 7.58E-03; Z-score: 7.72E-01

Methylation in Case

2.95E-01 (Median) Methylation in Control 2.70E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

TSS1500 (cg09746736)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.08E+00 Statistic Test p-value: 1.07E-02; Z-score: -2.11E-01

Methylation in Case

6.79E-02 (Median) Methylation in Control 7.34E-02 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

TSS1500 (cg16629702)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.13E+00 Statistic Test p-value: 3.71E-02; Z-score: -3.56E-01

Methylation in Case

5.80E-02 (Median) Methylation in Control 6.57E-02 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

TSS200 (cg09321400)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.64E+00 Statistic Test p-value: 1.90E-06; Z-score: 1.70E+00

Methylation in Case

2.61E-01 (Median) Methylation in Control 1.60E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

TSS200 (cg09774787)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.12E+00 Statistic Test p-value: 7.69E-05; Z-score: 3.18E-01

Methylation in Case

7.59E-02 (Median) Methylation in Control 6.78E-02 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

TSS200 (cg03226000)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.11E+00 Statistic Test p-value: 1.76E-03; Z-score: 3.59E-01

Methylation in Case

2.00E-01 (Median) Methylation in Control 1.79E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

Body (cg01206944)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.93E+00 Statistic Test p-value: 1.15E-19; Z-score: -3.77E+00

Methylation in Case

2.31E-01 (Median) Methylation in Control 4.47E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 13

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

Body (cg27323557)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.75E+00 Statistic Test p-value: 1.31E-19; Z-score: -8.78E+00

Methylation in Case

4.80E-01 (Median) Methylation in Control 8.39E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 14

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

Body (cg02863493)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.47E+00 Statistic Test p-value: 1.80E-17; Z-score: -2.46E+00

Methylation in Case

4.86E-01 (Median) Methylation in Control 7.17E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 15

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

Body (cg27072813)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.12E+00 Statistic Test p-value: 1.90E-17; Z-score: 1.79E+00

Methylation in Case

7.79E-01 (Median) Methylation in Control 6.96E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 16

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

Body (cg00877619)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.53E+00 Statistic Test p-value: 2.31E-16; Z-score: -3.52E+00

Methylation in Case

4.85E-01 (Median) Methylation in Control 7.42E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 17

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

Body (cg14075393)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.56E+00 Statistic Test p-value: 2.22E-14; Z-score: -3.54E+00

Methylation in Case

4.80E-01 (Median) Methylation in Control 7.50E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 18

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

Body (cg22615917)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.32E+00 Statistic Test p-value: 3.13E-13; Z-score: -5.50E+00

Methylation in Case

6.27E-01 (Median) Methylation in Control 8.28E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 19

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

Body (cg06925438)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.38E+00 Statistic Test p-value: 8.18E-12; Z-score: -4.53E+00

Methylation in Case

5.63E-01 (Median) Methylation in Control 7.75E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 20

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

Body (cg05981741)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.21E+00 Statistic Test p-value: 9.91E-12; Z-score: -9.17E+00

Methylation in Case

7.10E-01 (Median) Methylation in Control 8.60E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 21

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

Body (cg02629157)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.13E+00 Statistic Test p-value: 9.17E-11; Z-score: -5.07E+00

Methylation in Case

7.52E-01 (Median) Methylation in Control 8.53E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 22

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

Body (cg02935718)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.21E+00 Statistic Test p-value: 6.55E-09; Z-score: -2.27E+00

Methylation in Case

6.80E-01 (Median) Methylation in Control 8.25E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 23

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

Body (cg09382328)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.18E+00 Statistic Test p-value: 5.21E-08; Z-score: -1.48E+00

Methylation in Case

6.41E-01 (Median) Methylation in Control 7.54E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 24

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

Body (cg05067406)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.07E+00 Statistic Test p-value: 9.65E-08; Z-score: -1.63E+00

Methylation in Case

7.84E-01 (Median) Methylation in Control 8.42E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 25

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

Body (cg03860054)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.21E+00 Statistic Test p-value: 1.34E-07; Z-score: -2.43E+00

Methylation in Case

4.99E-01 (Median) Methylation in Control 6.03E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 26

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

Body (cg04450501)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.19E+00 Statistic Test p-value: 2.37E-07; Z-score: -1.81E+00

Methylation in Case

6.32E-01 (Median) Methylation in Control 7.53E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 27

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

Body (cg09554599)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 2.03E-06; Z-score: -1.92E+00

Methylation in Case

8.48E-01 (Median) Methylation in Control 8.77E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 28

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

Body (cg02471751)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 3.57E-03; Z-score: -4.21E-01

Methylation in Case

8.18E-01 (Median) Methylation in Control 8.26E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 29

Methylation of SLC6A2 in hepatocellular carcinoma [ 1 ]

Location

3'UTR (cg27579359)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 1.95E-03; Z-score: -1.26E-01

Methylation in Case

8.61E-01 (Median) Methylation in Control 8.66E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

Patient tissue samples

  Pancretic ductal adenocarcinoma

         11 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A2 in pancretic ductal adenocarcinoma [ 2 ]

Location

5'UTR (cg26119806)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.29E+00 Statistic Test p-value: 1.14E-04; Z-score: 1.20E+00

Methylation in Case

5.62E-01 (Median) Methylation in Control 4.37E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A2 in pancretic ductal adenocarcinoma [ 2 ]

Location

TSS1500 (cg21415530)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.39E+00 Statistic Test p-value: 9.42E-14; Z-score: 2.19E+00

Methylation in Case

5.81E-01 (Median) Methylation in Control 4.19E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC6A2 in pancretic ductal adenocarcinoma [ 2 ]

Location

TSS1500 (cg20567499)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.25E+00 Statistic Test p-value: 5.90E-03; Z-score: -6.26E-01

Methylation in Case

9.86E-02 (Median) Methylation in Control 1.23E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC6A2 in pancretic ductal adenocarcinoma [ 2 ]

Location

TSS200 (cg15638055)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.90E+00 Statistic Test p-value: 2.08E-34; Z-score: 5.45E+00

Methylation in Case

3.25E-01 (Median) Methylation in Control 1.71E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC6A2 in pancretic ductal adenocarcinoma [ 2 ]

Location

TSS200 (cg24290616)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.96E+00 Statistic Test p-value: 1.72E-11; Z-score: 2.01E+00

Methylation in Case

2.17E-01 (Median) Methylation in Control 1.10E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC6A2 in pancretic ductal adenocarcinoma [ 2 ]

Location

1stExon (cg14921743)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 5.99E+00 Statistic Test p-value: 6.13E-34; Z-score: 1.87E+01

Methylation in Case

3.24E-01 (Median) Methylation in Control 5.41E-02 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC6A2 in pancretic ductal adenocarcinoma [ 2 ]

Location

Body (cg12451099)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.42E+00 Statistic Test p-value: 7.81E-16; Z-score: 2.39E+00

Methylation in Case

4.47E-01 (Median) Methylation in Control 3.15E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC6A2 in pancretic ductal adenocarcinoma [ 2 ]

Location

Body (cg13610307)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.72E+00 Statistic Test p-value: 8.13E-15; Z-score: 2.99E+00

Methylation in Case

5.06E-01 (Median) Methylation in Control 2.94E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC6A2 in pancretic ductal adenocarcinoma [ 2 ]

Location

Body (cg14579898)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.20E+00 Statistic Test p-value: 1.04E-11; Z-score: 2.31E+00

Methylation in Case

5.21E-01 (Median) Methylation in Control 4.35E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC6A2 in pancretic ductal adenocarcinoma [ 2 ]

Location

Body (cg15427234)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.35E+00 Statistic Test p-value: 1.31E-05; Z-score: 1.94E+00

Methylation in Case

2.99E-01 (Median) Methylation in Control 2.21E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC6A2 in pancretic ductal adenocarcinoma [ 2 ]

Location

Body (cg12085314)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.42E+00 Statistic Test p-value: 2.60E-04; Z-score: -5.60E-01

Methylation in Case

4.53E-02 (Median) Methylation in Control 6.44E-02 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

Patient tissue samples

  Prostate cancer

         11 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A2 in prostate cancer [ 3 ]

Location

5'UTR (cg08831277)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.28E+00 Statistic Test p-value: 1.40E-02; Z-score: 2.21E+00

Methylation in Case

5.74E-02 (Median) Methylation in Control 4.48E-02 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A2 in prostate cancer [ 3 ]

Location

5'UTR (cg22584138)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.51E+00 Statistic Test p-value: 2.84E-02; Z-score: 2.18E+00

Methylation in Case

7.91E-01 (Median) Methylation in Control 5.25E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC6A2 in prostate cancer [ 3 ]

Location

TSS1500 (cg23029183)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.01E+00 Statistic Test p-value: 5.87E-03; Z-score: 2.58E+00

Methylation in Case

9.66E-01 (Median) Methylation in Control 9.52E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC6A2 in prostate cancer [ 3 ]

Location

TSS1500 (cg10859192)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.31E+00 Statistic Test p-value: 7.96E-03; Z-score: 2.19E+00

Methylation in Case

7.97E-01 (Median) Methylation in Control 6.10E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC6A2 in prostate cancer [ 3 ]

Location

TSS1500 (cg02428753)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.03E+00 Statistic Test p-value: 2.41E-02; Z-score: 1.79E+00

Methylation in Case

9.31E-01 (Median) Methylation in Control 9.00E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC6A2 in prostate cancer [ 3 ]

Location

TSS200 (cg07581732)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.86E+00 Statistic Test p-value: 2.06E-02; Z-score: -3.30E+00

Methylation in Case

8.09E-02 (Median) Methylation in Control 1.50E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC6A2 in prostate cancer [ 3 ]

Location

Body (cg02419920)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.22E+00 Statistic Test p-value: 9.10E-03; Z-score: 4.46E+00

Methylation in Case

7.90E-01 (Median) Methylation in Control 6.48E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC6A2 in prostate cancer [ 3 ]

Location

Body (cg09467487)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.10E+00 Statistic Test p-value: 1.66E-02; Z-score: 2.21E+00

Methylation in Case

8.65E-01 (Median) Methylation in Control 7.89E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC6A2 in prostate cancer [ 3 ]

Location

Body (cg12072789)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.10E+00 Statistic Test p-value: 4.12E-02; Z-score: 2.12E+00

Methylation in Case

8.56E-01 (Median) Methylation in Control 7.78E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC6A2 in prostate cancer [ 3 ]

Location

3'UTR (cg07658508)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.06E+00 Statistic Test p-value: 2.52E-02; Z-score: 3.93E+00

Methylation in Case

9.25E-01 (Median) Methylation in Control 8.72E-01 (Median)

Studied Phenotype

Prostate cancer [ ICD-11: 2C82]

Experimental Material

Patient tissue samples

  Bladder cancer

         14 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A2 in bladder cancer [ 4 ]

Location

TSS1500 (cg27047406)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.52E+00 Statistic Test p-value: 4.45E-05; Z-score: 6.39E+00

Methylation in Case

3.61E-01 (Median) Methylation in Control 2.38E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A2 in bladder cancer [ 4 ]

Location

TSS1500 (cg02693870)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.59E+00 Statistic Test p-value: 4.46E-04; Z-score: -3.56E+00

Methylation in Case

2.13E-01 (Median) Methylation in Control 3.38E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC6A2 in bladder cancer [ 4 ]

Location

TSS200 (cg03226000)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.36E+00 Statistic Test p-value: 4.73E-04; Z-score: 3.77E+00

Methylation in Case

1.97E-01 (Median) Methylation in Control 1.45E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC6A2 in bladder cancer [ 4 ]

Location

TSS200 (cg09774787)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.33E+00 Statistic Test p-value: 4.92E-03; Z-score: 2.03E+00

Methylation in Case

7.29E-02 (Median) Methylation in Control 5.49E-02 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC6A2 in bladder cancer [ 4 ]

Location

TSS200 (cg09321400)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.66E+00 Statistic Test p-value: 1.31E-02; Z-score: 1.69E+00

Methylation in Case

1.08E-01 (Median) Methylation in Control 6.52E-02 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC6A2 in bladder cancer [ 4 ]

Location

1stExon (cg04874129)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.79E+00 Statistic Test p-value: 1.16E-05; Z-score: 5.32E+00

Methylation in Case

2.85E-01 (Median) Methylation in Control 1.59E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC6A2 in bladder cancer [ 4 ]

Location

Body (cg04313338)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -2.61E+00 Statistic Test p-value: 1.46E-12; Z-score: -1.16E+01

Methylation in Case

1.44E-01 (Median) Methylation in Control 3.76E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC6A2 in bladder cancer [ 4 ]

Location

Body (cg27191081)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.11E+00 Statistic Test p-value: 2.89E-05; Z-score: -6.92E+00

Methylation in Case

8.02E-01 (Median) Methylation in Control 8.94E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC6A2 in bladder cancer [ 4 ]

Location

Body (cg03860054)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.10E+00 Statistic Test p-value: 9.52E-04; Z-score: 4.68E+00

Methylation in Case

6.34E-01 (Median) Methylation in Control 5.78E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC6A2 in bladder cancer [ 4 ]

Location

Body (cg09554599)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 5.16E-03; Z-score: -1.46E+00

Methylation in Case

8.86E-01 (Median) Methylation in Control 9.00E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC6A2 in bladder cancer [ 4 ]

Location

Body (cg05067406)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 9.93E-03; Z-score: -2.61E+00

Methylation in Case

8.51E-01 (Median) Methylation in Control 8.66E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of SLC6A2 in bladder cancer [ 4 ]

Location

Body (cg04450501)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.05E+00 Statistic Test p-value: 1.14E-02; Z-score: -4.47E+00

Methylation in Case

8.13E-01 (Median) Methylation in Control 8.50E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 13

Methylation of SLC6A2 in bladder cancer [ 4 ]

Location

Body (cg02935718)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 1.39E-02; Z-score: -1.26E+00

Methylation in Case

8.67E-01 (Median) Methylation in Control 8.83E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 14

Methylation of SLC6A2 in bladder cancer [ 4 ]

Location

3'UTR (cg27579359)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.05E+00 Statistic Test p-value: 7.99E-04; Z-score: -5.21E+00

Methylation in Case

8.51E-01 (Median) Methylation in Control 8.90E-01 (Median)

Studied Phenotype

Bladder cancer [ ICD-11: 2C94]

Experimental Material

Patient tissue samples

  Breast cancer

         21 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A2 in breast cancer [ 5 ]

Location

TSS1500 (cg27047406)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.39E+00 Statistic Test p-value: 2.02E-10; Z-score: 2.93E+00

Methylation in Case

3.95E-01 (Median) Methylation in Control 2.84E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A2 in breast cancer [ 5 ]

Location

TSS1500 (cg16629702)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.02E+00 Statistic Test p-value: 7.24E-08; Z-score: 1.69E+00

Methylation in Case

8.71E-02 (Median) Methylation in Control 4.31E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC6A2 in breast cancer [ 5 ]

Location

TSS1500 (cg02693870)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.37E+00 Statistic Test p-value: 4.63E-07; Z-score: -1.93E+00

Methylation in Case

3.27E-01 (Median) Methylation in Control 4.49E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC6A2 in breast cancer [ 5 ]

Location

TSS1500 (cg10362591)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.45E+00 Statistic Test p-value: 2.87E-06; Z-score: 1.29E+00

Methylation in Case

1.92E-01 (Median) Methylation in Control 1.33E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC6A2 in breast cancer [ 5 ]

Location

TSS1500 (cg09746736)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.25E+00 Statistic Test p-value: 4.36E-04; Z-score: 7.52E-01

Methylation in Case

8.67E-02 (Median) Methylation in Control 6.95E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC6A2 in breast cancer [ 5 ]

Location

TSS1500 (cg01277542)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.42E+00 Statistic Test p-value: 1.51E-03; Z-score: 2.95E-01

Methylation in Case

2.97E-02 (Median) Methylation in Control 2.09E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC6A2 in breast cancer [ 5 ]

Location

TSS200 (cg09321400)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 4.40E+00 Statistic Test p-value: 1.49E-17; Z-score: 4.82E+00

Methylation in Case

2.73E-01 (Median) Methylation in Control 6.20E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC6A2 in breast cancer [ 5 ]

Location

TSS200 (cg03226000)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.97E+00 Statistic Test p-value: 8.79E-15; Z-score: 3.43E+00

Methylation in Case

2.68E-01 (Median) Methylation in Control 1.36E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC6A2 in breast cancer [ 5 ]

Location

TSS200 (cg09774787)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.76E+00 Statistic Test p-value: 1.43E-10; Z-score: 4.70E+00

Methylation in Case

1.11E-01 (Median) Methylation in Control 4.02E-02 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC6A2 in breast cancer [ 5 ]

Location

1stExon (cg04874129)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.03E+00 Statistic Test p-value: 1.91E-02; Z-score: 1.82E-01

Methylation in Case

2.74E-01 (Median) Methylation in Control 2.65E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC6A2 in breast cancer [ 5 ]

Location

Body (cg04313338)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.50E+00 Statistic Test p-value: 8.06E-16; Z-score: -2.81E+00

Methylation in Case

2.66E-01 (Median) Methylation in Control 3.99E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of SLC6A2 in breast cancer [ 5 ]

Location

Body (cg09382328)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.15E+00 Statistic Test p-value: 1.12E-12; Z-score: -2.76E+00

Methylation in Case

7.53E-01 (Median) Methylation in Control 8.68E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 13

Methylation of SLC6A2 in breast cancer [ 5 ]

Location

Body (cg04450501)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.16E+00 Statistic Test p-value: 5.32E-12; Z-score: -3.01E+00

Methylation in Case

7.33E-01 (Median) Methylation in Control 8.54E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 14

Methylation of SLC6A2 in breast cancer [ 5 ]

Location

Body (cg02935718)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.13E+00 Statistic Test p-value: 3.54E-11; Z-score: -2.30E+00

Methylation in Case

7.83E-01 (Median) Methylation in Control 8.89E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 15

Methylation of SLC6A2 in breast cancer [ 5 ]

Location

Body (cg03519481)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.11E+00 Statistic Test p-value: 6.24E-10; Z-score: -1.86E+00

Methylation in Case

7.70E-01 (Median) Methylation in Control 8.54E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 16

Methylation of SLC6A2 in breast cancer [ 5 ]

Location

Body (cg03860054)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.07E+00 Statistic Test p-value: 1.31E-08; Z-score: -1.41E+00

Methylation in Case

6.61E-01 (Median) Methylation in Control 7.04E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 17

Methylation of SLC6A2 in breast cancer [ 5 ]

Location

Body (cg09554599)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.05E+00 Statistic Test p-value: 7.44E-08; Z-score: -1.83E+00

Methylation in Case

8.40E-01 (Median) Methylation in Control 8.86E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 18

Methylation of SLC6A2 in breast cancer [ 5 ]

Location

Body (cg05067406)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 1.04E-06; Z-score: -1.31E+00

Methylation in Case

8.18E-01 (Median) Methylation in Control 8.63E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 19

Methylation of SLC6A2 in breast cancer [ 5 ]

Location

Body (cg02471751)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 2.69E-06; Z-score: -8.94E-01

Methylation in Case

8.27E-01 (Median) Methylation in Control 8.47E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 20

Methylation of SLC6A2 in breast cancer [ 5 ]

Location

Body (cg27191081)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.11E+00 Statistic Test p-value: 2.36E-03; Z-score: -6.07E-01

Methylation in Case

7.98E-01 (Median) Methylation in Control 8.87E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 21

Methylation of SLC6A2 in breast cancer [ 5 ]

Location

3'UTR (cg27579359)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.18E+00 Statistic Test p-value: 6.61E-07; Z-score: -1.70E+00

Methylation in Case

7.49E-01 (Median) Methylation in Control 8.86E-01 (Median)

Studied Phenotype

Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

Patient tissue samples

  Renal cell carcinoma

           8 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A2 in clear cell renal cell carcinoma [ 6 ]

Location

TSS1500 (cg10362591)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.12E+00 Statistic Test p-value: 2.24E-06; Z-score: 1.76E+00

Methylation in Case

1.29E-01 (Median) Methylation in Control 6.07E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A2 in clear cell renal cell carcinoma [ 6 ]

Location

TSS1500 (cg27047406)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.34E+00 Statistic Test p-value: 3.79E-05; Z-score: 2.43E+00

Methylation in Case

3.33E-01 (Median) Methylation in Control 2.48E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC6A2 in clear cell renal cell carcinoma [ 6 ]

Location

TSS1500 (cg16629702)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.60E+00 Statistic Test p-value: 4.72E-04; Z-score: 2.05E+00

Methylation in Case

3.96E-02 (Median) Methylation in Control 2.47E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC6A2 in clear cell renal cell carcinoma [ 6 ]

Location

TSS1500 (cg09746736)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.22E+00 Statistic Test p-value: 1.71E-03; Z-score: 7.37E-01

Methylation in Case

5.36E-02 (Median) Methylation in Control 4.38E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC6A2 in clear cell renal cell carcinoma [ 6 ]

Location

TSS1500 (cg02693870)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.33E+00 Statistic Test p-value: 2.43E-03; Z-score: -1.97E+00

Methylation in Case

3.01E-01 (Median) Methylation in Control 4.00E-01 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC6A2 in clear cell renal cell carcinoma [ 6 ]

Location

TSS200 (cg03226000)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.12E+00 Statistic Test p-value: 8.40E-07; Z-score: 1.70E+00

Methylation in Case

1.52E-01 (Median) Methylation in Control 7.20E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC6A2 in clear cell renal cell carcinoma [ 6 ]

Location

TSS200 (cg09774787)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.57E+00 Statistic Test p-value: 4.06E-04; Z-score: 1.63E+00

Methylation in Case

4.06E-02 (Median) Methylation in Control 2.59E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC6A2 in clear cell renal cell carcinoma [ 6 ]

Location

1stExon (cg04874129)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.82E+00 Statistic Test p-value: 2.34E-05; Z-score: 1.65E+00

Methylation in Case

1.45E-01 (Median) Methylation in Control 8.00E-02 (Median)

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patient tissue samples

  Colon cancer

           8 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A2 in colon adenocarcinoma [ 7 ]

Location

TSS1500 (cg08628584)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.91E+00 Statistic Test p-value: 1.80E-05; Z-score: 9.97E+00

Methylation in Case

3.12E-01 (Median) Methylation in Control 1.07E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A2 in colon adenocarcinoma [ 7 ]

Location

TSS200 (cg06964816)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.25E+00 Statistic Test p-value: 1.12E-04; Z-score: -1.52E+00

Methylation in Case

2.87E-01 (Median) Methylation in Control 3.57E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC6A2 in colon adenocarcinoma [ 7 ]

Location

Body (cg19702785)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.22E+00 Statistic Test p-value: 1.18E-06; Z-score: 2.08E+00

Methylation in Case

5.18E-01 (Median) Methylation in Control 4.24E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC6A2 in colon adenocarcinoma [ 7 ]

Location

Body (cg04590638)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.33E+00 Statistic Test p-value: 2.45E-06; Z-score: -4.39E+00

Methylation in Case

5.83E-01 (Median) Methylation in Control 7.74E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC6A2 in colon adenocarcinoma [ 7 ]

Location

Body (cg18869815)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.26E+00 Statistic Test p-value: 1.29E-05; Z-score: -2.74E+00

Methylation in Case

5.11E-01 (Median) Methylation in Control 6.43E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC6A2 in colon adenocarcinoma [ 7 ]

Location

Body (cg09562675)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.18E+00 Statistic Test p-value: 9.75E-05; Z-score: -2.47E+00

Methylation in Case

5.26E-01 (Median) Methylation in Control 6.23E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC6A2 in colon adenocarcinoma [ 7 ]

Location

Body (cg04437194)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 3.03E-04; Z-score: -1.68E+00

Methylation in Case

8.43E-01 (Median) Methylation in Control 8.77E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC6A2 in colon adenocarcinoma [ 7 ]

Location

Body (cg14435098)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.08E+00 Statistic Test p-value: 4.10E-04; Z-score: -1.07E+00

Methylation in Case

6.88E-01 (Median) Methylation in Control 7.39E-01 (Median)

Studied Phenotype

Colon cancer [ ICD-11: 2B90]

Experimental Material

Patient tissue samples

  Colorectal cancer

         19 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A2 in colorectal cancer [ 8 ]

Location

TSS1500 (cg09746736)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 5.30E+00 Statistic Test p-value: 2.35E-20; Z-score: 1.11E+01

Methylation in Case

4.98E-01 (Median) Methylation in Control 9.38E-02 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A2 in colorectal cancer [ 8 ]

Location

TSS1500 (cg01277542)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 9.36E+00 Statistic Test p-value: 1.97E-19; Z-score: 1.35E+01

Methylation in Case

4.09E-01 (Median) Methylation in Control 4.37E-02 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC6A2 in colorectal cancer [ 8 ]

Location

TSS1500 (cg10362591)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.70E+00 Statistic Test p-value: 3.48E-14; Z-score: 2.81E+00

Methylation in Case

7.13E-01 (Median) Methylation in Control 4.19E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC6A2 in colorectal cancer [ 8 ]

Location

TSS1500 (cg16629702)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.65E+00 Statistic Test p-value: 2.49E-11; Z-score: 3.08E+00

Methylation in Case

3.43E-01 (Median) Methylation in Control 1.29E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC6A2 in colorectal cancer [ 8 ]

Location

TSS1500 (cg27047406)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.33E+00 Statistic Test p-value: 6.37E-08; Z-score: 1.95E+00

Methylation in Case

7.81E-01 (Median) Methylation in Control 5.86E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC6A2 in colorectal cancer [ 8 ]

Location

TSS200 (cg09774787)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.83E+00 Statistic Test p-value: 3.60E-14; Z-score: 3.96E+00

Methylation in Case

6.24E-01 (Median) Methylation in Control 2.21E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC6A2 in colorectal cancer [ 8 ]

Location

TSS200 (cg03226000)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.36E+00 Statistic Test p-value: 9.15E-07; Z-score: 1.65E+00

Methylation in Case

8.12E-01 (Median) Methylation in Control 5.98E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC6A2 in colorectal cancer [ 8 ]

Location

TSS200 (cg09321400)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.46E+00 Statistic Test p-value: 3.04E-05; Z-score: 1.24E+00

Methylation in Case

6.47E-01 (Median) Methylation in Control 4.42E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC6A2 in colorectal cancer [ 8 ]

Location

1stExon (cg04874129)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.23E+00 Statistic Test p-value: 8.78E-05; Z-score: 1.12E+00

Methylation in Case

6.28E-01 (Median) Methylation in Control 5.09E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC6A2 in colorectal cancer [ 8 ]

Location

Body (cg04450501)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.21E+00 Statistic Test p-value: 2.97E-12; Z-score: -6.35E+00

Methylation in Case

7.29E-01 (Median) Methylation in Control 8.82E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC6A2 in colorectal cancer [ 8 ]

Location

Body (cg02935718)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.07E+00 Statistic Test p-value: 1.44E-07; Z-score: -2.03E+00

Methylation in Case

8.13E-01 (Median) Methylation in Control 8.69E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of SLC6A2 in colorectal cancer [ 8 ]

Location

Body (cg03519481)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 1.14E-06; Z-score: -3.55E+00

Methylation in Case

8.55E-01 (Median) Methylation in Control 9.06E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 13

Methylation of SLC6A2 in colorectal cancer [ 8 ]

Location

Body (cg09382328)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.12E+00 Statistic Test p-value: 6.19E-05; Z-score: -1.32E+00

Methylation in Case

7.27E-01 (Median) Methylation in Control 8.12E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 14

Methylation of SLC6A2 in colorectal cancer [ 8 ]

Location

Body (cg27191081)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.05E+00 Statistic Test p-value: 1.13E-03; Z-score: -1.14E+00

Methylation in Case

8.37E-01 (Median) Methylation in Control 8.80E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 15

Methylation of SLC6A2 in colorectal cancer [ 8 ]

Location

Body (cg09554599)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 1.66E-03; Z-score: -7.95E-01

Methylation in Case

9.43E-01 (Median) Methylation in Control 9.49E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 16

Methylation of SLC6A2 in colorectal cancer [ 8 ]

Location

Body (cg02471751)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.00E+00 Statistic Test p-value: 9.09E-03; Z-score: -3.78E-01

Methylation in Case

9.28E-01 (Median) Methylation in Control 9.31E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 17

Methylation of SLC6A2 in colorectal cancer [ 8 ]

Location

Body (cg04313338)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.18E+00 Statistic Test p-value: 2.70E-02; Z-score: -4.67E-01

Methylation in Case

3.00E-01 (Median) Methylation in Control 3.54E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 18

Methylation of SLC6A2 in colorectal cancer [ 8 ]

Location

3'UTR (cg27579359)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 3.37E-03; Z-score: -1.96E-01

Methylation in Case

8.65E-01 (Median) Methylation in Control 8.70E-01 (Median)

Studied Phenotype

Colorectal cancer [ ICD-11: 2B91]

Experimental Material

Patient tissue samples

  HIV infection

         13 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A2 in HIV infection [ 9 ]

Location

TSS1500 (cg16629702)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.86E+00 Statistic Test p-value: 1.06E-05; Z-score: 2.28E+00

Methylation in Case

7.76E-02 (Median) Methylation in Control 4.17E-02 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A2 in HIV infection [ 9 ]

Location

TSS1500 (cg10362591)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.49E+00 Statistic Test p-value: 5.50E-05; Z-score: 1.63E+00

Methylation in Case

2.01E-01 (Median) Methylation in Control 1.35E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC6A2 in HIV infection [ 9 ]

Location

TSS1500 (cg27047406)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.24E+00 Statistic Test p-value: 2.04E-04; Z-score: 1.41E+00

Methylation in Case

3.51E-01 (Median) Methylation in Control 2.84E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC6A2 in HIV infection [ 9 ]

Location

TSS1500 (cg09746736)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.38E+00 Statistic Test p-value: 1.20E-03; Z-score: 1.62E+00

Methylation in Case

7.91E-02 (Median) Methylation in Control 5.74E-02 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC6A2 in HIV infection [ 9 ]

Location

TSS1500 (cg01277542)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.00E+00 Statistic Test p-value: 3.24E-03; Z-score: 8.23E-01

Methylation in Case

4.05E-02 (Median) Methylation in Control 2.02E-02 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC6A2 in HIV infection [ 9 ]

Location

TSS200 (cg09321400)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.34E+00 Statistic Test p-value: 1.30E-06; Z-score: 3.01E+00

Methylation in Case

1.41E-01 (Median) Methylation in Control 6.01E-02 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC6A2 in HIV infection [ 9 ]

Location

TSS200 (cg03226000)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.39E+00 Statistic Test p-value: 2.29E-05; Z-score: 1.44E+00

Methylation in Case

1.91E-01 (Median) Methylation in Control 1.38E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC6A2 in HIV infection [ 9 ]

Location

TSS200 (cg09774787)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.63E+00 Statistic Test p-value: 6.21E-04; Z-score: 1.37E+00

Methylation in Case

4.79E-02 (Median) Methylation in Control 2.95E-02 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC6A2 in HIV infection [ 9 ]

Location

1stExon (cg04874129)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.24E+00 Statistic Test p-value: 9.42E-04; Z-score: 1.27E+00

Methylation in Case

2.59E-01 (Median) Methylation in Control 2.09E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC6A2 in HIV infection [ 9 ]

Location

Body (cg04450501)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 1.09E-04; Z-score: -1.46E+00

Methylation in Case

8.23E-01 (Median) Methylation in Control 8.75E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC6A2 in HIV infection [ 9 ]

Location

Body (cg03519481)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 1.76E-04; Z-score: -7.38E-01

Methylation in Case

8.82E-01 (Median) Methylation in Control 8.99E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of SLC6A2 in HIV infection [ 9 ]

Location

Body (cg09382328)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 1.99E-03; Z-score: -9.41E-01

Methylation in Case

8.27E-01 (Median) Methylation in Control 8.62E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 13

Methylation of SLC6A2 in HIV infection [ 9 ]

Location

3'UTR (cg27579359)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 6.86E-03; Z-score: -9.20E-01

Methylation in Case

9.07E-01 (Median) Methylation in Control 9.24E-01 (Median)

Studied Phenotype

HIV infection [ ICD-11: 1C62.Z]

Experimental Material

Patient tissue samples

  Lung adenocarcinoma

         13 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A2 in lung adenocarcinoma [ 10 ]

Location

TSS1500 (cg10362591)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.26E+00 Statistic Test p-value: 5.29E-03; Z-score: 5.99E+00

Methylation in Case

3.65E-01 (Median) Methylation in Control 1.62E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A2 in lung adenocarcinoma [ 10 ]

Location

TSS1500 (cg01277542)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 4.54E+00 Statistic Test p-value: 1.22E-02; Z-score: 5.37E+00

Methylation in Case

1.58E-01 (Median) Methylation in Control 3.48E-02 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC6A2 in lung adenocarcinoma [ 10 ]

Location

TSS1500 (cg16629702)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.30E+00 Statistic Test p-value: 1.29E-02; Z-score: 7.13E+00

Methylation in Case

1.54E-01 (Median) Methylation in Control 6.71E-02 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC6A2 in lung adenocarcinoma [ 10 ]

Location

TSS1500 (cg27047406)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.16E+00 Statistic Test p-value: 2.77E-02; Z-score: 1.33E+00

Methylation in Case

3.65E-01 (Median) Methylation in Control 3.14E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC6A2 in lung adenocarcinoma [ 10 ]

Location

TSS1500 (cg09746736)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.24E+00 Statistic Test p-value: 2.85E-02; Z-score: 1.55E+00

Methylation in Case

1.54E-01 (Median) Methylation in Control 1.25E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC6A2 in lung adenocarcinoma [ 10 ]

Location

TSS200 (cg03226000)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.41E+00 Statistic Test p-value: 2.61E-03; Z-score: 8.97E+00

Methylation in Case

4.04E-01 (Median) Methylation in Control 1.68E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC6A2 in lung adenocarcinoma [ 10 ]

Location

TSS200 (cg09321400)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 2.91E+00 Statistic Test p-value: 2.66E-03; Z-score: 1.06E+01

Methylation in Case

3.38E-01 (Median) Methylation in Control 1.16E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC6A2 in lung adenocarcinoma [ 10 ]

Location

TSS200 (cg09774787)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 4.09E+00 Statistic Test p-value: 6.96E-03; Z-score: 1.24E+01

Methylation in Case

1.81E-01 (Median) Methylation in Control 4.41E-02 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC6A2 in lung adenocarcinoma [ 10 ]

Location

1stExon (cg04874129)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.43E+00 Statistic Test p-value: 5.26E-03; Z-score: 2.43E+00

Methylation in Case

2.99E-01 (Median) Methylation in Control 2.09E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC6A2 in lung adenocarcinoma [ 10 ]

Location

Body (cg09382328)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.06E+00 Statistic Test p-value: 8.58E-03; Z-score: -2.06E+00

Methylation in Case

8.01E-01 (Median) Methylation in Control 8.52E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC6A2 in lung adenocarcinoma [ 10 ]

Location

Body (cg04450501)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.07E+00 Statistic Test p-value: 1.87E-02; Z-score: -2.86E+00

Methylation in Case

7.89E-01 (Median) Methylation in Control 8.45E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 12

Methylation of SLC6A2 in lung adenocarcinoma [ 10 ]

Location

Body (cg02935718)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 3.73E-02; Z-score: -1.81E+00

Methylation in Case

8.65E-01 (Median) Methylation in Control 8.87E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 13

Methylation of SLC6A2 in lung adenocarcinoma [ 10 ]

Location

3'UTR (cg27579359)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.05E+00 Statistic Test p-value: 2.61E-02; Z-score: -5.70E+00

Methylation in Case

8.49E-01 (Median) Methylation in Control 8.88E-01 (Median)

Studied Phenotype

Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

Patient tissue samples

  Panic disorder

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A2 in panic disorder [ 11 ]

Location

TSS1500 (cg16629702)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -9.48E-01 Statistic Test p-value: 1.30E-02; Z-score: -5.03E-01

Methylation in Case

-5.50E+00 (Median) Methylation in Control -5.22E+00 (Median)

Studied Phenotype

Panic disorder [ ICD-11: 6B01]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A2 in panic disorder [ 11 ]

Location

TSS200 (cg09321400)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -9.47E-01 Statistic Test p-value: 2.17E-02; Z-score: -5.04E-01

Methylation in Case

-5.29E+00 (Median) Methylation in Control -5.00E+00 (Median)

Studied Phenotype

Panic disorder [ ICD-11: 6B01]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC6A2 in panic disorder [ 11 ]

Location

Body (cg03860054)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.09E+00 Statistic Test p-value: 2.38E-02; Z-score: 4.64E-01

Methylation in Case

1.98E+00 (Median) Methylation in Control 1.82E+00 (Median)

Studied Phenotype

Panic disorder [ ICD-11: 6B01]

Experimental Material

Patient tissue samples

  Papillary thyroid cancer

         10 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A2 in papillary thyroid cancer [ 12 ]

Location

TSS1500 (cg16629702)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.12E+00 Statistic Test p-value: 3.72E-03; Z-score: 5.37E-01

Methylation in Case

7.00E-02 (Median) Methylation in Control 6.27E-02 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A2 in papillary thyroid cancer [ 12 ]

Location

TSS1500 (cg01277542)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.21E+00 Statistic Test p-value: 1.84E-02; Z-score: 4.43E-01

Methylation in Case

4.34E-02 (Median) Methylation in Control 3.58E-02 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC6A2 in papillary thyroid cancer [ 12 ]

Location

TSS200 (cg09321400)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.23E+00 Statistic Test p-value: 4.73E-03; Z-score: 4.75E-01

Methylation in Case

8.78E-02 (Median) Methylation in Control 7.14E-02 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC6A2 in papillary thyroid cancer [ 12 ]

Location

TSS200 (cg09774787)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.03E+00 Statistic Test p-value: 3.39E-02; Z-score: 1.66E-01

Methylation in Case

6.45E-02 (Median) Methylation in Control 6.24E-02 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC6A2 in papillary thyroid cancer [ 12 ]

Location

Body (cg04313338)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.27E+00 Statistic Test p-value: 9.06E-11; Z-score: -1.66E+00

Methylation in Case

2.20E-01 (Median) Methylation in Control 2.80E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC6A2 in papillary thyroid cancer [ 12 ]

Location

Body (cg09382328)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 1.02E-08; Z-score: -1.81E+00

Methylation in Case

8.94E-01 (Median) Methylation in Control 9.22E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC6A2 in papillary thyroid cancer [ 12 ]

Location

Body (cg02935718)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.03E+00 Statistic Test p-value: 2.24E-06; Z-score: -1.29E+00

Methylation in Case

9.14E-01 (Median) Methylation in Control 9.37E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC6A2 in papillary thyroid cancer [ 12 ]

Location

Body (cg27191081)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 8.77E-04; Z-score: -6.51E-01

Methylation in Case

8.84E-01 (Median) Methylation in Control 8.99E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC6A2 in papillary thyroid cancer [ 12 ]

Location

Body (cg05067406)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.02E+00 Statistic Test p-value: 9.64E-04; Z-score: -8.55E-01

Methylation in Case

8.49E-01 (Median) Methylation in Control 8.69E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC6A2 in papillary thyroid cancer [ 12 ]

Location

Body (cg09554599)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 1.07E-02; Z-score: -7.28E-01

Methylation in Case

9.33E-01 (Median) Methylation in Control 9.41E-01 (Median)

Studied Phenotype

Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

Patient tissue samples

  Systemic lupus erythematosus

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A2 in systemic lupus erythematosus [ 13 ]

Location

TSS1500 (cg09746736)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.07E+00 Statistic Test p-value: 4.50E-03; Z-score: -1.17E-01

Methylation in Case

5.54E-02 (Median) Methylation in Control 5.93E-02 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A2 in systemic lupus erythematosus [ 13 ]

Location

Body (cg05067406)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.01E+00 Statistic Test p-value: 1.44E-02; Z-score: -2.66E-01

Methylation in Case

8.90E-01 (Median) Methylation in Control 8.97E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC6A2 in systemic lupus erythematosus [ 13 ]

Location

Body (cg04313338)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 3.52E-02; Z-score: -2.20E-01

Methylation in Case

3.59E-01 (Median) Methylation in Control 3.72E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC6A2 in systemic lupus erythematosus [ 13 ]

Location

3'UTR (cg27579359)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.00E+00 Statistic Test p-value: 4.42E-02; Z-score: -8.26E-02

Methylation in Case

8.69E-01 (Median) Methylation in Control 8.72E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

Patient tissue samples

  Atypical teratoid rhabdoid tumor

         11 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A2 in atypical teratoid rhabdoid tumor [ 14 ]

Location

1stExon (cg04874129)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.41E+00 Statistic Test p-value: 4.09E-24; Z-score: -4.53E+00

Methylation in Case

5.82E-01 (Median) Methylation in Control 8.21E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 2

Methylation of SLC6A2 in atypical teratoid rhabdoid tumor [ 14 ]

Location

Body (cg02471751)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.17E+00 Statistic Test p-value: 1.65E-04; Z-score: 6.50E-01

Methylation in Case

7.28E-01 (Median) Methylation in Control 6.23E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 3

Methylation of SLC6A2 in atypical teratoid rhabdoid tumor [ 14 ]

Location

Body (cg02935718)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.12E+00 Statistic Test p-value: 2.39E-04; Z-score: 5.97E-01

Methylation in Case

8.84E-01 (Median) Methylation in Control 7.92E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 4

Methylation of SLC6A2 in atypical teratoid rhabdoid tumor [ 14 ]

Location

Body (cg03519481)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.11E+00 Statistic Test p-value: 3.66E-04; Z-score: -8.49E-01

Methylation in Case

7.91E-01 (Median) Methylation in Control 8.81E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 5

Methylation of SLC6A2 in atypical teratoid rhabdoid tumor [ 14 ]

Location

Body (cg03860054)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.11E+00 Statistic Test p-value: 4.46E-04; Z-score: 7.01E-01

Methylation in Case

8.32E-01 (Median) Methylation in Control 7.50E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 6

Methylation of SLC6A2 in atypical teratoid rhabdoid tumor [ 14 ]

Location

Body (cg04313338)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.04E+00 Statistic Test p-value: 7.16E-04; Z-score: -6.28E-01

Methylation in Case

8.09E-01 (Median) Methylation in Control 8.43E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 7

Methylation of SLC6A2 in atypical teratoid rhabdoid tumor [ 14 ]

Location

Body (cg04450501)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.13E+00 Statistic Test p-value: 7.76E-04; Z-score: 2.22E-01

Methylation in Case

1.01E-01 (Median) Methylation in Control 8.96E-02 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 8

Methylation of SLC6A2 in atypical teratoid rhabdoid tumor [ 14 ]

Location

Body (cg05067406)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.26E+00 Statistic Test p-value: 1.22E-03; Z-score: 8.44E-01

Methylation in Case

6.10E-01 (Median) Methylation in Control 4.84E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 9

Methylation of SLC6A2 in atypical teratoid rhabdoid tumor [ 14 ]

Location

Body (cg09382328)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: 1.03E+00 Statistic Test p-value: 1.04E-02; Z-score: 2.48E-01

Methylation in Case

9.14E-01 (Median) Methylation in Control 8.85E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 10

Methylation of SLC6A2 in atypical teratoid rhabdoid tumor [ 14 ]

Location

Body (cg09554599)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.08E+00 Statistic Test p-value: 1.11E-02; Z-score: -2.64E-01

Methylation in Case

4.11E-01 (Median) Methylation in Control 4.42E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon 11

Methylation of SLC6A2 in atypical teratoid rhabdoid tumor [ 14 ]

Location

3'UTR (cg27579359)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.28E+00 Statistic Test p-value: 3.58E-09; Z-score: -1.69E+00

Methylation in Case

5.91E-01 (Median) Methylation in Control 7.56E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

Patient tissue samples

  Celiac disease

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Methylation of SLC6A2 in celiac disease [ 15 ]

Location

Body (cg09382328)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change: -1.29E+00 Statistic Test p-value: 1.42E-02; Z-score: -1.00E+00

Methylation in Case

5.76E-01 (Median) Methylation in Control 7.46E-01 (Median)

Studied Phenotype

Celiac disease [ ICD-11: DA95]

Experimental Material

Patient tissue samples

  Heart Failure

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Hypermethylation of SLC6A2 in heart failure [ 17 ]

Location

Promoter

Epigenetic Type

Methylation Experiment Method Bisulfite pyrosequencing

Studied Phenotype

Heart Failure [ ICD-11: BD1Z]

Experimental Material

Patient tissue samples

Additional Notes

Abnormally elevated methylation of the promoter region of SLC6A2 gene is one of risk factors for HF.

  Gastric cancer

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Moderate/significant hypermethylation of SLC6A2 in gastric cancer than that in healthy individual/adjacent tissue

Studied Phenotype

Gastric cancer [ICD-11:2B72]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 8.31E-30; Fold-change: 0.232201419; Z-score: 2.502835697

The Methylation Level of Disease Section Compare with the Adjacent Tissue

p-value: 9.92E-07; Fold-change: 0.337073085; Z-score: 15.74821257
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue adjacent to the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals

  Prostate cancer metastasis

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Significant hypermethylation of SLC6A2 in prostate cancer metastasis than that in healthy individual

Studied Phenotype

Prostate cancer metastasis [ICD-11:2.00E+06]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value: 0.010330017; Fold-change: 0.306588867; Z-score: 22.72625771
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

Histone acetylation

  Neuroblastoma cells treatment with CRF

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Hyperacetylation of SLC6A2 in corticotropin releasing factor (CRF) treatment neuroblastoma cells (compare with counterpart neuroblastoma cells) [ 16 ]

Location

Promoter

Epigenetic Type

Histone acetylation Experiment Method Chromatin immunoprecipitation

Related Molecular Changes

Up regulation of SLC6A2 Experiment Method RT-qPCR

Studied Phenotype

Neuroblastoma cells treatment with CRF

Experimental Material

Multiple cell lines of human

Additional Notes

Chromatin immunoprecipitation assays confirm an increased acetylation of histone H3 on the NET promoter following treatment with CRF.
References
1 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
2 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
3 Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014 Jan 22;15:51.
4 DNA Methylation Dynamics in Urological Tumors.
5 Genome-wide Scan for Methylation Profiles in Breast Cancer
6 A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma. Nat Commun. 2015 Oct 30;6:8699.
7 Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips. Epigenetics. 2013 Sep;8(9):921-34.
8 Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
9 HIV-1 Infection Accelerates Age According to the Epigenetic Clock. J Infect Dis. 2015 Nov 15;212(10):1563-73.
10 DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues
11 DNA Methylation signatures in panic disorder. Transl Psychiatry. 2017 Dec 18;7(12):1287.
12 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
13 Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. PLoS Genet. 2013;9(8):e1003678.
14 Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes. Cancer Cell. 2016 Mar 14;29(3):379-393.
15 The methylome of the celiac intestinal epithelium harbours genotype-independent alterations in the HLA region. Mol Ther Oncolytics. 2019 Feb 5;12:235-245.
16 Corticotropin releasing factor up-regulates the expression and function of norepinephrine transporter in SK-N-BE (2) M17 cells. J Neurochem. 2015 Oct;135(1):38-49.
17 Methylation in Promoter Region of SLC6A2 Gene in Heart Failure Patients and Its Correlation with Qi Deficiency/Blood Stasis Syndrome. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2015 Dec;35(12):1448-54.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.